Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Bruno Lucidi

At a glance: Bruno Lucidi is Director at Atea Pharmaceuticals (AVIR). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $27K. On file: 0 purchase lines ($0) and 2 sale lines ($116K).

Disclosed holdings: about $737K of AVIR stock: 187,990 shares reported on their latest Form 4 (filed Nov 19, 2026), valued at the Nov 20, 2026 close of $3.92. This counts only AVIR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Atea Pharmaceuticals, Inc. (AVIR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $116K

Bruno Lucidi's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Bruno Lucidi: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 19SEC AVIRAtea Pharmaceuticals, Inc. Sell 6,741157,237 held (−4%) $4.03 $27K -2.8%
Nov 19SEC AVIRAtea Pharmaceuticals, Inc. Sell 22,619187,990 held (−11%) $3.94 $89K -0.6%

Follow Bruno Lucidi

Get one email when Bruno Lucidi files a new purchase or sale. Free.

At most one email a day about Bruno Lucidi, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.